Tradestie Institutional Equity Comparison Engine
OGEN vs MTNB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MTNB Overall Edge
MTNB Captures Institutional Edge (1โ0 Pillars ยท 4โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Matinas BioPharma Holdings, Inc. (MTNB) driven by superior Momentum & Technical. Fundamentally, OGEN trades at N/M Forward P/E with 0.0% operating margin (-91.3% YoY revenue) versus MTNB at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, OGEN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
OGEN N/M vs MTNB N/M Fwd P/E
Growth & Margin Winner
Tie
Op Margin 0.0% vs 0.0% ยท YoY -91.3% vs -100.0%
Momentum & Technical Winner
MTNB
1Y -84.1% vs -31.4% ยท 52W Pos 4% vs 22%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OGEN
NYSE American
Oragenics Inc.
Pharmaceutical Preparations
$0.17
-8.99% 1D
Market Cap
$852,759
1M Return
-58.33%
1Y Return
-84.11%
Forward P/E
N/M
Unified AI Score
40.8 / 100
SELL
Tech 30.0
Fund 50.0
Flow 50.0
Mom 75.0
MTNB
NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap
$979,904
1M Return
-46.7%
1Y Return
-31.35%
Forward P/E
N/M
Unified AI Score
54.6 / 100
HOLD
Tech 53.0
Fund 58.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OGEN -84.11%
MTNB -31.35%
Spread: +52.76 pp (MTNB Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | OGEN Revenue | MTNB Revenue | OGEN Op. Margin | MTNB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2015 | N/A | $0M | N/A | -5096.0% | MTNB |
| FY2017 | N/A | $0M | N/A | -11024.6% | MTNB |
| FY2018 | N/A | $0M | N/A | -12230.9% | MTNB |
| FY2019 | N/A | $0M | N/A | -21067.4% | MTNB |
| FY2020 | N/A | $0M | N/A | -15288.4% | MTNB |
| FY2021 | $0M | $0M | -18130.3% | -74954.5% | OGEN |
| FY2022 | $0M | $0M | -10964.6% | -771.3% | MTNB |
| FY2023 | $0M | $0M | -55519.9% | -2168.4% | MTNB |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OGEN | MTNB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $852,759 | $979,904 | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -91.3% | -100.0% | Higher Growth | OGEN |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -1307.1% | -147.5% | Higher ROE | MTNB |
| 52-Week Range Position Momentum | 4% ($0โ$1) | 22% ($0โ$3) | Stronger Trend | MTNB |
| Beta / 30D Volatility Risk Regime | 1.23ฮฒ ยท 154% Vol | -7.20ฮฒ ยท 147% Vol | Lower Realized Risk | MTNB |
| Unified Institutional Score Composite Signal | 40.8 / 100 (SELL) | 54.6 / 100 (HOLD) | Higher Composite | MTNB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OGEN vs MTNB Buy Guide
OGEN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MTNB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OGEN nor MTNB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.